Comparative effectiveness and safety of apixaban, dabigatran, and rivaroxaban in patients with non-valvular atrial fibrillation
NW Andersson, H Svanström, M Lund… - International journal of …, 2018 - Elsevier
Background The comparative effectiveness and safety of individual direct oral
anticoagulants (DOACs) in clinical practice is largely unknown. The study objectives were to …
anticoagulants (DOACs) in clinical practice is largely unknown. The study objectives were to …
Direct comparisons of effectiveness and safety of treatment with Apixaban, Dabigatran and Rivaroxaban in atrial fibrillation
M Jansson, S Själander, V Sjögren, H Renlund… - Thrombosis …, 2020 - Elsevier
Abstract Introduction Direct oral anticoagulants (DOACs) have been proven non-inferior or
superior to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
superior to warfarin in preventing stroke and systemic embolism, with a lower risk of major …
Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large …
TC Villines, A Ahmad, M Petrini, W Tang… - European Heart …, 2019 - academic.oup.com
Aims We used the US Department of Defense Military Health System database to compare
the safety and effectiveness of direct oral anticoagulants (DOACs) in patients with non …
the safety and effectiveness of direct oral anticoagulants (DOACs) in patients with non …
[HTML][HTML] Comparative effectiveness of warfarin, dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation: A nationwide pharmacoepidemiological study
LJ Kjerpeseth, R Selmer, I Ariansen, Ø Karlstad… - PLoS …, 2019 - journals.plos.org
Objective To compare effectiveness and safety of warfarin and the direct oral anticoagulants
(DOAC) dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation in routine …
(DOAC) dabigatran, rivaroxaban and apixaban in non-valvular atrial fibrillation in routine …
Effectiveness and safety of dabigatran, rivaroxaban, and apixaban versus warfarin in nonvalvular atrial fibrillation
X Yao, NS Abraham, LR Sangaralingham… - Journal of the …, 2016 - Am Heart Assoc
Background The introduction of non–vitamin K antagonist oral anticoagulants has been a
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
major advance for stroke prevention in atrial fibrillation; however, outcomes achieved in …
Differences in safety and efficacy of oral anticoagulants in patients with non‐valvular atrial fibrillation: A Bayesian analysis
Z Sun, Y Liu, Y Zhang, X Guo… - International Journal of …, 2019 - Wiley Online Library
Background Novel oral anticoagulants are the cornerstone of therapy for non‐valvular atrial
fibrillation patients to lower the risk of ischaemic stroke. Given the lack of head‐to‐head …
fibrillation patients to lower the risk of ischaemic stroke. Given the lack of head‐to‐head …
[HTML][HTML] Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of …
Background Clinical trials have demonstrated that direct oral anticoagulants (DOACs) are at
least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among …
least non-inferior to warfarin in reducing the risk of stroke/systemic embolism (SE) among …
Comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in atrial fibrillation: a nationwide cohort study
OCW Rutherford, C Jonasson… - European Heart …, 2020 - academic.oup.com
Aims The aim of this study was to compare the risk of stroke or systemic embolism (SE) and
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …
major bleeding in patients with atrial fibrillation (AF) using dabigatran, rivaroxaban, and …
Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation
J Pink, M Pirmohamed… - Clinical Pharmacology & …, 2013 - Wiley Online Library
Alternative anticoagulants to warfarin (dabigatran, rivaroxaban, and apixaban) are
becoming available for the prevention of thromboembolic stroke in atrial fibrillation (AF), but …
becoming available for the prevention of thromboembolic stroke in atrial fibrillation (AF), but …
Direct comparison of dabigatran, rivaroxaban, and apixaban for effectiveness and safety in nonvalvular atrial fibrillation
PA Noseworthy, X Yao, NS Abraham… - Chest, 2016 - Elsevier
Background The introduction of non-vitamin K antagonist oral anticoagulants (NOACs) has
been a major advance for stroke prevention in atrial fibrillation (AF). Patients and clinicians …
been a major advance for stroke prevention in atrial fibrillation (AF). Patients and clinicians …
相关搜索
- atrial fibrillation effectiveness and safety
- dabigatran rivaroxaban apixaban for effectiveness
- safety of apixaban rivaroxaban in patients
- atrial fibrillation dabigatran rivaroxaban
- treatment with apixaban effectiveness and safety
- atrial fibrillation treatment with apixaban
- atrial fibrillation direct comparisons
- atrial fibrillation oral anticoagulants
- direct comparison apixaban for effectiveness
- fibrillation patients defense population
- defense population effectiveness and safety
- atrial fibrillation bayesian analysis
- effectiveness of dabigatran apixaban in patients
- dabigatran rivaroxaban effectiveness and safety
- fibrillation patients effectiveness and safety
- atrial fibrillation apixaban for effectiveness